Rockwell Medical (RMTI) Short-term Investments (2010 - 2026)

Rockwell Medical's Short-term Investments history runs 17 years deep, the most recent figure standing at $14.3 million for Q1 2026.

• Quarterly Short-term Investments rose 140.42% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 140.42% YoY) and the FY2025 annual result came in at $14.3 million, up 140.51% from the prior year.
• Short-term Investments was $14.3 million for Q1 2026 at Rockwell Medical, roughly flat from $14.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $14.6 million in Q3 2022 and bottomed at $2.0 million in Q4 2023.
• A 5-year average of $7.7 million and a median of $5.9 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2023 — Short-term Investments sank 82.86% — and 2024, when it soared 204.3%.
• Rockwell Medical's Short-term Investments stood at $11.4 million in 2022, then sank by 82.86% to $2.0 million in 2023, then surged by 204.3% to $5.9 million in 2024, then jumped by 140.51% to $14.3 million in 2025, then slipped by 0.03% to $14.3 million in 2026.
• Business Quant data shows RMTI's Short-term Investments at $14.3 million in Q1 2026, $14.3 million in Q4 2025, and $10.1 million in Q3 2025.